Vol. 90 No. 7-S (2019): The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders: Guest Editor: Giorgio Ciprandi

View Vol. 90 No. 7-S (2019): The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders: Guest Editor: Giorgio Ciprandi
Published: 09-07-2019

  • The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders

    Giorgio Ciprandi, Salvo Emanuele Aragona, Lorenzo Drago, Ignazio La Mantia
    5-7
    DOI: https://doi.org/10.23750/abm.v90i7-S.8648

  • Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders

    Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
    8-12
    DOI: https://doi.org/10.23750/abm.v90i7-S.8649

  • Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation

    Luigi Bonavina, Andrea Ariani, Leonardo Ficano, Domenico Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Lorenzo Drago, Giorgio Ciprandi, Italian Study Group on digestive disorders
    13-17
    DOI: https://doi.org/10.23750/abm.v90i7-S.8650

  • Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01)

    Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
    18-23
    DOI: https://doi.org/10.23750/abm.v90i7-S.8651

  • Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice

    Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
    24-29
    DOI: https://doi.org/10.23750/abm.v90i7-S.8654

  • Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice

    Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
    30-35
    DOI: https://doi.org/10.23750/abm.v90i7-S.8655

  • Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice

    Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
    36-40
    DOI: https://doi.org/10.23750/abm.v90i7-S.8656

  • VAS for assessing the perception of antihistamines use in allergic rhinitis

    Giorgio Ciprandi, Ignazio La Mantia
    41-44
    DOI: https://doi.org/10.23750/abm.v90i7-S.8657

  • Influence of cigarette smoking on allergic rhinitis: a comparative study on smokers and non-smokers

    Calogero Grillo, Ignazio La Mantia, Caterina M Grillo, Giorgio Ciprandi, Martina Ragusa, Claudio Andaloro
    45-51
    DOI: https://doi.org/10.23750/abm.v90i7-S.8658

  • Oral health in children with sleep-disordered breathing: a cross-sectional study

    Calogero Grillo, Ignazio La Mantia, Graziano Zappala, Salvatore Cocuzza, Giorgio Ciprandi, Claudio Andaloro
    52-59
    DOI: https://doi.org/10.23750/abm.v90i7-S.8661